These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32557526)

  • 1. Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.
    Fiandaca MS; Lonser RR; Elder JB; Ząbek M; Bankiewicz KS
    Neurol Neurochir Pol; 2020; 54(3):220-231. PubMed ID: 32557526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-based therapies in Parkinson's disease.
    Allen PJ; Feigin A
    Neurotherapeutics; 2014 Jan; 11(1):60-7. PubMed ID: 24129887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound targeted CNS gene delivery for Parkinson's disease treatment.
    Fan CH; Lin CY; Liu HL; Yeh CK
    J Control Release; 2017 Sep; 261():246-262. PubMed ID: 28690161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the Latest Computerized Technologies Revolutionize Conventional Assessment Tools and Therapies for a Neurological Disease? The Example of Parkinson's Disease.
    Asakawa T; Sugiyama K; Nozaki T; Sameshima T; Kobayashi S; Wang L; Hong Z; Chen S; Li C; Namba H
    Neurol Med Chir (Tokyo); 2019 Mar; 59(3):69-78. PubMed ID: 30760657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
    Piguet F; Alves S; Cartier N
    Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Parkinson's disease : what's on the horizon?
    Wu SS; Frucht SJ
    CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease.
    Lam MF; Thomas MG; Lind CR
    J Clin Neurosci; 2011 Sep; 18(9):1163-7. PubMed ID: 21745745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery.
    Miranpuri GS; Kumbier L; Hinchman A; Schomberg D; Wang A; Marshall H; Kubota K; Ross C; Sillay K
    Ann Neurosci; 2012 Jul; 19(3):133-46. PubMed ID: 25205986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson's disease.
    Ulusoy A; Kirik D
    Ther Deliv; 2011 Jan; 2(1):37-50. PubMed ID: 22833924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
    Buttery PC; Barker RA
    Neurotherapeutics; 2020 Oct; 17(4):1539-1562. PubMed ID: 33128174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and new challenges in Parkinson's disease therapeutics.
    Pires AO; Teixeira FG; Mendes-Pinheiro B; Serra SC; Sousa N; Salgado AJ
    Prog Neurobiol; 2017 Sep; 156():69-89. PubMed ID: 28457671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy: a viable therapeutic strategy for Parkinson's disease?
    Berry AL; Foltynie T
    J Neurol; 2011 Feb; 258(2):179-88. PubMed ID: 20963433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
    Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
    Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The studies of gene therapy for Parkinson's disease].
    Mochizuki H
    Rinsho Shinkeigaku; 2009 Jan; 49(1):9-16. PubMed ID: 19227890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.
    Douglas MR
    Expert Rev Neurother; 2013 Jun; 13(6):695-705. PubMed ID: 23739006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug delivery systems for releasing growth factors to the CNS: focus on Alzheimer's and Parkinson's diseases.
    Herran E; Igartua M; Pedraz JL; Hernandez RM
    Mini Rev Med Chem; 2014; 14(7):557-66. PubMed ID: 24958218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for Parkinson's disease: contemporary practice and emerging concepts.
    Merola A; Van Laar A; Lonser R; Bankiewicz K
    Expert Rev Neurother; 2020 Jun; 20(6):577-590. PubMed ID: 32425079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to ex vivo gene therapy in the treatment of Parkinson's disease.
    Ishida A; Yasuzumi F
    Brain Dev; 2000 Sep; 22 Suppl 1():S143-7. PubMed ID: 10984676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.